GLP1R and type 2 diabetes mellitus: In patients with T2DM, 6 weeks of continuous GLP-1 infusion significantly reduced HbA1c, fasting glucose, and post-prandial glucose excursions compared with placebo (PBO) infusion (Fig. 3).